CD274 and urothelial carcinoma: The upregulation of PD-L1 expression by tumor cells, however, is thought to be a mechanism by which solid tumors develop a tolerance to immune regulation [15]; however, the detailed mechanism of PD-L1 in urothelial carcinoma remains unknown.